Exploring the genetic basis of stroke. Spanish stroke genetics consortium;Aproximación al conocimiento de las bases genéticas del ictus. Consorcio español de genética del ictus

Neurologia

Volumn 29, Issue 9, 2014, Pages 560-566

  Giralt Steinhauer, E ^a   Jimenez Conde J ^a   Soriano Tarraga C ^a   Mola, M ^a   Rodriguez Campello A ^a   Cuadrado Godia, E ^a   Ois, A ^a   Fernandez Cadenas I ^b   Carrera, C ^b   Montaner, J ^b   Diaz Navarro R M ^c   Vives Bauza C ^c   Roquer, J ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Association; Consortium; Genetic risk factors; Genetics; Prediction; Stroke

Indexed keywords

CEREBROVASCULAR ACCIDENT; GENETIC ASSOCIATION; GENETIC RISK; GENETICS; HUMAN; SCIENTIFIC LITERATURE; SHORT SURVEY; SPAIN; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 84922514932     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2013.04.005     Document Type: Short Survey

References (49)

1. Alvarez Sabin J. In-hospital mortality in stroke patients. Rev Esp Cardiol 2008, 61:1007-1009.
2. Truelsen T., Piechowski-Jozwiak B., Bonita R., Mathers C., Bogousslavsky J., Boysen G. Stroke incidence and prevalence in europe: A review of available data. Eur J Neurol 2006, 13:581-598.
3. Grau A.J., Weimar C., Buggle F., Heinrich A., Goertler M., Neumaier S., et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: The german stroke data bank. Stroke 2001, 32:2559-2566.
4. Bevan S., Traylor M., Adib-Samii P., Malik R., Paul N.L., Jackson C., et al. Genetic heritability of ischemic stroke and the contribution of previously reported candidate gene and genomewide associations. Stroke 2012, 43:3161-3167.
5. A haplotype map of the human genome. Nature 2005, 437:1299-1320. International HapMap Consortium.
6. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science 1996, 273:1516-1517.
7. Jerrard-Dunne P., Cloud G., Hassan A., Markus H.S. Evaluating the genetic component of ischemic stroke subtypes: A family history study. Stroke 2003, 34:1364-1369.
8. Traylor M., Farrall M., Holliday E.G., Sudlow C., Hopewell J.C., Cheng Y.C., et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): A meta-analysis of genome-wide association studies. Lancet Neurol 2012, 11:951-962.
9. Caplan L.R. Intracerebral haemorrhage. Lancet 1992, 339:656-658.
10. Flaherty M.L., Woo D., Broderick J. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and hispanics. Neurology 2006, 66:956-957. author reply 956-957.
11. Tabor H.K., Risch N.J., Myers R.M. Candidate-gene approaches for studying complex genetic traits: Practical considerations. Nat Rev Genet 2002, 3:391-397.
12. Dichgans M., Markus H.S. Genetic association studies in stroke: Methodological issues and proposed standard criteria. Stroke 2005, 36:2027-2031.
13. Kuo D.S., Labelle-Dumais C., Gould D.B. COL4A1 and COL4A2 mutations and disease: Insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 2012, 21(R1):R97-R110.
14. Breedveld G., de Coo I.F., Lequin M.H., Arts W.F., Heutink P., Gould D.B., et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. J Med Genet 2006, 43:490-495.
15. Gould D.B., Phalan F.C., van Mil S.E., Sundberg J.P., Vahedi K., Massin P., et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006, 354:1489-1496.
16. Weng Y.C., Sonni A., Labelle-Dumais C., de Leau M., Kauffman W.B., Jeanne M., et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol 2012, 71:470-477.
17. Biffi A., Sonni A., Anderson C.D., Kissela B., Jagiella J.M., Schmidt H., et al. Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol 2010, 68:934-943.
18. Biffi A., Anderson C.D., Jagiella J.M., Schmidt H., Kissela B., Hansen B.M., et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: A genetic association study. Lancet Neurol 2011, 10:702-709.
19. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861. International HapMap Consortium.
20. Visscher P.M., Hill W.G., Wray N.R. Heritability in the genomics era--concepts and misconceptions. Nat Rev Genet 2008, 9:255-266.
21. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., et al. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
22. Marchini J., Cardon L.R., Phillips M.S., Donnelly P. The effects of human population structure on large genetic association studies. Nat Genet 2004, 36:512-517.
23. Neale B.M., Purcell S. The positives, protocols, and perils of genome-wide association. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1288-1294.
24. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
25. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000, 26:76-80.
26. Florez J.C., Hirschhorn J., Altshuler D. The inherited basis of diabetes mellitus: Implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 2003, 4:257-291.
27. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
28. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
29. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
30. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
31. Markus H.S. Stroke genetics. Hum Mol Genet 2011, 20(R2):R124-R131.
32. Lemmens R., Buysschaert I., Geelen V., Fernandez-Cadenas I., Montaner J., Schmidt H., et al. The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology. Stroke 2010, 41:1850-1857.
33. Gudbjartsson D.F., Holm H., Gretarsdottir S., Thorleifsson G., Walters G.B., Thorgeirsson G., et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat Genet 2009, 41:876-878.
34. Gschwendtner A., Bevan S., Cole J.W., Plourde A., Matarin M., Ross-Adams H., et al. Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 2009, 65:531-539.
35. Bellenguez C., Bevan S., Gschwendtner A., Spencer C.C., Burgess A.I., Pirinen M., et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012, 44:328-333. International Stroke Genetics Consortium (ISGC), Wellcome Trust Case Control Consortium 2 (WTCCC2).
36. Kubo M., Hata J., Ninomiya T., Matsuda K., Yonemoto K., Nakano T., et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet 2007, 39:212-217.
37. Cole J.W., Stine O.C., Liu X., Pratap A., Cheng Y., Tallon L.J., et al. Rare variants in ischemic stroke: An exome pilot study. PLoS One 2012, 7:e35591.
38. Iafrate A.J., Feuk L., Rivera M.N., Listewnik M.L., Donahoe P.K., Qi Y., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
39. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
40. Pollex R.L., Hegele R.A. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007, 115:3130-3138.
41. Matarin M., Simon-Sanchez J., Fung H.C., Scholz S., Gibbs J.R., Hernandez D.G., et al. Structural genomic variation in ischemic stroke. Neurogenetics 2008, 9:101-108.
42. Qureshi I.A., Mehler M.F. Emerging role of epigenetics in stroke: Part 1: DNA methylation and chromatin modifications. Arch Neurol 2010, 67:1316-1322.
43. Skiriute D., Vaitkiene P., Saferis V., Asmoniene V., Skauminas K., Deltuva V.P., et al. MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma. BMC Cancer 2012, 12:218.
44. Baccarelli A., Wright R., Bollati V., Litonjua A., Zanobetti A., Tarantini L., et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 2010, 21:819-828.
45. Falcone G.J., Biffi A., Devan W.J., Jagiella J.M., Schmidt H., Kissela B., et al. Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage. Stroke 2012.
46. Park Y.K., Bang O.S., Cha M.H., Kim J., Cole J.W., Lee D., et al. SigCS base: An integrated genetic information resource for human cerebral stroke. BMC Syst Biol. 2011, 14(5 Suppl 2.). S10.0509-5-S2-S10. Epub 2011 Dec 14.
47. Ramoni R.B., Himes B.E., Sale M.M., Furie K.L., Ramoni M.F. Predictive genomics of cardioembolic stroke. Stroke 2009, 40(3 Suppl):S67-S70.
48. Bell C.G., Finer S., Lindgren C.M., Wilson G.A., Rakyan V.K., Teschendorff A.E., et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 2010, 5:e14040.
49. Krug T., Gabriel J.P., Taipa R., Fonseca B.V., Domingues-Montanari S., Fernandez-Cadenas I., et al. TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches. J Cereb Blood Flow Metab 2012, 32:1061-1072.